Somatic mosaicism in chronic myeloid leukemia in remission-Reference-Cited by-同舟云学术

Somatic mosaicism in chronic myeloid leukemia in remission

Published:2016-12-15 Issue:24 Volume:128 Page:2863-2866
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Mitani Kinuko¹,Nagata Yasunobu²,Sasaki Ko¹,Yoshida Kenichi²,Chiba Kenichi³,Tanaka Hiroko⁴,Shiraishi Yuichi⁴,Miyano Satoru³⁴,Makishima Hideki²,Nakamura Yukitsugu¹,Nakamura Yuka¹,Ichikawa Motoshi¹,Ogawa Seishi²

Affiliation:

1. Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, Tochigi, Japan;

2. Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan; and

3. Laboratory of Sequence Data Analysis, Human Genome Center, and

4. Laboratory of DNA Information Analysis, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/128/24/2863/1358044/blood723494.pdf

Reference21 articles.

1. Chronic myeloid leukaemia;Apperley;Lancet,2015

2. Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority;Bumm;Blood,2003

3. Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib;Loriaux;Leuk Lymphoma,2004

4. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months’ experience;Braziel;Blood,2002

5. Frequent pathway mutations of splicing machinery in myelodysplasia;Yoshida;Nature,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic landscape of chronic myeloid leukemia;International Journal of Hematology;2022-12-07

2. From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care;Expert Review of Hematology;2022-11-01

3. Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia;Cancers;2022-07-06

4. Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance;Cancers;2021-09-26

5. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia;Nature Communications;2021-05-14